Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man
- 1 June 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (6) , 588-595
- https://doi.org/10.1016/0026-0495(92)90050-k
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.Journal of Clinical Investigation, 1990
- Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemiaMetabolism, 1989
- Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bileHepatology, 1988
- Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects A double blind testAtherosclerosis, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapyJournal of Lipid Research, 1988
- Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjectsAtherosclerosis, 1988
- Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.Journal of Clinical Investigation, 1987
- Gas-liquid chromatographic determination of fecal neutral sterols using a capillary columnClinica Chimica Acta; International Journal of Clinical Chemistry, 1982
- A Simplified Method for the Determination of Chromic Oxide (Cr 2 O 3 ) when Used as an Index SubstanceScience, 1952